Hepatocellular carcinoma in thalassemia: A critical review - Wikidata - awgldk - TriplyDB

Hepatocellular carcinoma in thalassemia: A critical review

Hepatocellular carcinoma in thalassemia: A critical review

http://www.wikidata.org/entity/Q34391592

about

Hepatocellular Carcinoma and Liver Transplantation: State of the Art β-thalassemia intermedia: a clinical perspective Novel approach to reactive oxygen species in nontransfusion-dependent thalassemia Pathophysiology and Clinical Manifestations of the β-Thalassemias.Management of hepatocellular carcinoma: Enlightening the gray zones.Use of magnetic resonance imaging to monitor iron overload Secondary haemochromatosis in a patient with thalassemia intermedia Hepatitis C virus infection in thalassemic patients with and without insulin dependent diabetes.Liver Iron Concentration and Liver Impairment in Relation to Serum IGF-1 Levels in Thalassaemia Major Patients: A Retrospective Study.Successful Treatment of Hepatocellular Carcinoma Complicated by Fanconi Anemia.Hepatic iron overload in the portal tract predicts poor survival in hepatocellular carcinoma after curative resection.

P2860

Q26781798-6D728850-1193-4491-81D6-473B3C3B952B Q26828512-412DEF41-49B7-4F1F-8754-CF8A1B9CE4CD Q33993973-27234325-5C00-4DB8-A9A4-A6739841249B Q36526536-6F903FCE-2CDA-4DAE-8D23-7B2FCBB77861 Q36955647-FD5DF523-A890-438A-9C0B-D23866FF5E8E Q38234248-7C854B7D-42E4-46B9-A0D2-498D0E831C2B Q39114227-AFEC45D9-760A-4A7A-BB6E-A1DC358AE1B3 Q41456483-5ACCBBE6-7EAC-4B99-AA5A-7C2402066FBC Q41815077-11925F5F-1459-42C1-A940-7950BE864932 Q41988114-ACD362D7-512F-49EF-81EE-202F85C00072 Q48361923-31B83310-F7A6-4624-A5FB-B01C704B2A5F

P2860

Hepatocellular carcinoma in thalassemia: A critical review

http://www.wikidata.org/entity/Q34391592

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Hepatocellular carcinoma in thalassemia: A critical review

@ast

Hepatocellular carcinoma in thalassemia: A critical review

@en

Hepatocellular carcinoma in thalassemia: A critical review

@nl

type

label

Hepatocellular carcinoma in thalassemia: A critical review

@ast

Hepatocellular carcinoma in thalassemia: A critical review

@en

Hepatocellular carcinoma in thalassemia: A critical review

@nl

prefLabel

Hepatocellular carcinoma in thalassemia: A critical review

@ast

Hepatocellular carcinoma in thalassemia: A critical review

@en

Hepatocellular carcinoma in thalassemia: A critical review

@nl

P1433

Q34391592-7DD7DE1D-066E-4E15-91AA-C35C87C591CC

P1476

Q34391592-38C7281E-8254-4E42-A3B3-05B4A5C32EF1

P2093

Q34391592-20A341B0-2B6A-403B-9B3D-C34F8815F340

P2860

Q34391592-122C944A-F47E-430D-88C6-1920AA6F95FC

Q34391592-24E798ED-FE8D-4F31-AFF0-D4CE5C749290

Q34391592-39C8531F-3F37-49D5-B2BF-28909EB4F129

Q34391592-47DB0502-7503-4246-B828-9A9BB1794C1D

Q34391592-4EF6E6E9-1167-4657-B4EB-DE9D733C7C94

Q34391592-534AA7E5-C5C1-4148-95F8-EC9AEAEC0ED4

Q34391592-681F569B-8A37-4AD4-ACB5-1E6C6C2FABCE

Q34391592-7F1C76B7-4F24-4520-850D-5A687168ACE1

Q34391592-83AB17DF-9D35-43D9-A0EB-515E94651F79

Q34391592-84327C19-053D-47FC-B60A-86D7F726F58B

P304

Q34391592-29E66950-3B31-490E-83FF-BA4198C1F492

P31

Q34391592-64f96626-489c-4f55-9fb8-6fedbc702e0c

Q34391592-E5104F57-F155-498C-ADFF-355669507E2A

P356

Q34391592-A45C8B83-1A9D-48B6-81DC-2DAE6A2DD0A5

P433

Q34391592-4C9FF007-78D6-467A-9B9F-A4036B997F93

P478

Q34391592-022A0FC9-BDCA-473F-A7E8-06C53508C624

P577

Q34391592-D6409E8D-15A2-40DD-BF5C-AE5EDAD8D94E

P5875

Q34391592-26358FC8-326D-406A-9454-CB0E2F53A5E2

P698

Q34391592-57A9E5CE-7A60-4971-8727-F949A326E17E

P932

Q34391592-2FCE7979-4780-40D1-A6E1-64B87409C2CE

P356

P1433

World journal of hepatology

P1476

Hepatocellular carcinoma in thalassemia: A critical review

@en

P2093

Andrea Mancuso

http://www.w3.org/2001/XMLSchema#string

P2860

Oral deferiprone for iron chelation in people with thalassaemia

Hepatocellular carcinoma

Management of hepatocellular carcinoma

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Iron, hemochromatosis, and hepatocellular carcinoma.

Alpha interferon treatment of chronic hepatitis C in beta-thalassaemia

Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance.

Novel advancements in the management of hepatocellular carcinoma in 2008.

Screening for hepatocellular carcinoma in cirrhosis.

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008.

P304

171-174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4254/WJH.V2.I5.171

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49686024

http://www.w3.org/2001/XMLSchema#string

P698

21160991

http://www.w3.org/2001/XMLSchema#string

P932

2999281

http://www.w3.org/2001/XMLSchema#string